Prosecution Insights
Last updated: October 04, 2026

Squire Pb (Sfr Office)

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

162 pending office actions • 82 clients • 157 examiners • 89 art units • 10 of 162 (6%) have an AI response strategy ready

Quality Metrics (n=12389 apps, methodology: how we score firms)

83.1%
Allowance Rate
n=12389
+0.46σ
Allowance Rate (norm)
n=12389
3.8
OAs to Allowance
n=8288
+0.15σ
OAs to Allow (norm)
n=8288
1103 days
Time to Allowance
n=8288
+11.4pp
Interview Lift
n=12389
31.2%
RCE Rate
n=12389
2.5%
Appeal Rate
n=12389

Rejection Performance (% of received rejections ultimately overcome)

82.0%
§101 Overcome
n=1424
79.8%
§102 Overcome
n=3627
80.8%
§103 Overcome
n=5811
82.2%
§112 Overcome
n=3556

Specialization & Scale

H04W, H04L, G06F
Top CPC Subclasses
22%
Top-3 CPC Share
n=12389
13
Practitioners
n=12389
953.0
Apps / Practitioner
n=12389

Portfolio Summary

162
Total Pending OAs
106
Non-Final OAs
51
Final Rejections
5
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 38 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

17
Overdue
2
Due this week
11
Due this month
5
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 38 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (17)Due ≤ 7 days (2)Due ≤ 30 days (11)Due ≤ 60 days (5)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

65
Hard (40%)
66
Medium (41%)
30
Easy (19%)
1
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only1 (1%)
§101 + other12 (7%)
§103 only47 (29%)
§102 only6 (4%)
§112 only23 (14%)
Double-patenting only7 (4%)
Double-patenting + other13 (8%)
Multi-statute (no §101)52 (32%)
No statute on record1 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

83
Life Sciences
51% of docket
19
Information Tech
12% of docket
10
Communications
6% of docket
7
Semiconductors
4% of docket
12
Mechanical / Eng
7% of docket
31
Business / Other
19% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,620 h
Manual time on pending OAs
324 h
Time saved (low, 20%)
567 h
Time saved (mid, 35%)
14.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FRASER, STEWART A 2 85.9% +14.5%
NGUYEN, CHUONG M 2 72.7% +19.4%
GAUGER, PAUL RANDALL 2 56.0% +12.1%
CHACKO DAVIS, DABORAH 2 72.1% +20.6%
VINEIS, FRANK J 2 39.9% +44.8%
CORNET, JEAN P 1 42.1% +47.5%
MERRIAM, ANDREW E 1 26.8% +32.4%
BOWERS, ERIN M 1 54.7% +10.6%
CATTANACH, COLIN J 1 59.0% +19.9%
LAFONTANT, GARY 1 73.5% +1.5%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18727041 PHASE SHIFT MASK AND METHOD FOR MANUFACTURING PHASE SHIFT MASK FRASER, STEWART A —
18277053 REFLECTIVE PHOTOMASK BLANK AND REFLECTIVE PHOTOMASK FRASER, STEWART A —

Hard Cases (65)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18728655 METHOD AND APPARATUS FOR SPLITTING DOWNLINK DATA IN A DUAL/MULTI CONNECTIVITY SYSTEM DONABED, NINOS 111d overdue
18027825 OPERATION METHOD AND OPERATION DEVICE FOR LIVING BODY BOWERS, NATHAN ANDREW 77d overdue
18985088 Apparatus Utilizing Smart Fabrics for Providing Protection of the Head and Brain from Injury in Six Degrees of Freedom NUNNERY, GRADY ALEXANDER 46d overdue
18033187 COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS MOU, LIYUAN 45d overdue
18074369 METHOD OF MAPPING SPATIAL DISTRIBUTIONS OF CELLULAR COMPONENTS LU, FRANK WEI MIN 43d overdue
19112742 UNITARY REAR RAIL STRUCTURE FOR A VEHICLE AND METHODS O'NEILL, MATTHEW JAMES 9d overdue
17886039 ELECTRONIC COMPONENT WITH MOULDED PACKAGE HIBBERT, DANIEL JOHNATHAN 9d overdue
18273261 ACYL ACTIVATING ENZYMES FOR PREPARATION OF CANNABINOIDS SAIDHA, TEKCHAND 1d overdue

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18558005 TRANSMISSION FOR TIME SYNCHRONIZATION NGUYEN, CHUONG M 35d overdue
19537121 N-PHENYL-3-(2,5-DIOXOPYRROLIDIN-1-YL)PROPANAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS DUX4 INHIBITORS FOR THE TREATMENT OF E.G. NEUROMUSCULAR DISORDERS CORNET, JEAN P —
19531099 FIBER BLEND COMPOSITIONS AND METHODS OF USE THEREOF MERRIAM, ANDREW E —
19366131 Products and Methods for Therapeutic Administration of Microorganisms to Non-Human Animals BOWERS, ERIN M —
19345449 DISPLAY DEVICE CATTANACH, COLIN J —
18727041 PHASE SHIFT MASK AND METHOD FOR MANUFACTURING PHASE SHIFT MASK FRASER, STEWART A —
18704362 CONTROLLING ACCESS FOR DEVICES WITH DIFFERENT CAPABILITIES NGUYEN, CHUONG M —
18605432 METHODS AND USES OF BORON COMPOUNDS IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIUM INFECTIONS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SAME GAUGER, PAUL RANDALL —

Client Portfolio (82 clients)

Client (Assignee)Pending OAs
Nokia 23
QuantumScape 8
TEKSCEND PHOTOMASK CORP. 8
California Institute of Technology 5
Nalux 4
NIKON CORPORATION 4
SUTRO BIOPHARMA, INC. 4
Tosoh 3
ENGENE, INC. 3
KONICA MINOLTA, INC. 3
CALYXO, INC. 3
Berkeley Fermentation Science Inc. 3
BIOGEN MA INC. 3
NURIX THERAPEUTICS, INC. 3
INMED PHARMACEUTICALS INC. 3
Animal Microbiome Analytics, Inc. 2
SOLARWINDS WORLDWIDE, LLC 2
We Plan For S.A. 2
Nikang Therapeutics Inc. 2
PRELLIS BIOLOGICS, INC. 2
AMYRIS, INC. 2
Inventor-E Limited 2
Toppan 2
ELUCIDERM INC. 2
KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC. 2
Shanghai Micurx Pharmaceuticals Co., Ltd. 2
NEURO-BIO LTD 2
Curadev Pharma Pvt. Ltd. 2
Octet Scientific, Inc. 2
CJ Group 2
Altay Therapeutics, Inc. 1
Astellas Pharama Inc. 1
Orthodontic Research And Development, S.L. 1
Gve Ltd. 1
Sumitomo 1
Gestamp 1
Keiji Ikemori 1
Varidesk, LLC 1
Scarfe Technologies, Inc. 1
Gale Pacific Limited 1
Innengine, S.L. 1
Emerson 1
Specialty Minerals (Michigan) Inc. 1
Automated Industrial Robotics Wakefield Limited 1
Dermoq, Inc. 1
Repsol, S.A 1
Isosterix, Inc. 1
REMBRAND, INC. 1
Carbonbuilt, Inc. 1
Wenzhou Adopharm Technology Co., Ltd. 1
Oji Holdings 1
Love Random Life 1
VIE, INC. 1
Micurx Pharmeceuticals, Inc. 1
Aspect Biosystems Ltd. 1
Lightbridge Corporation 1
PTC Therapeutics 1
Polypeptide Therapeutic Solutions, S.L. 1
Shanghai Micurx Pharmaceutical Co., Ltd. 1
Consejo Superior de Investigaciones Científicas 1
Toppan Tomoegawa Optical Films Co., Ltd. 1
Osaka Gas 1
Innovo Therapeutics, Inc. 1
UNITED KINGDOM RESEARCH AND INNOVATION 1
THE CLEVELAND CLINIC FOUNDATION 1
BAYMEDICA, INC. 1
Biome Bioplastics 1
Teneoseven, Inc. 1
Albert-Ludwigs-Universität Freiburg 1
Hospital Sant Joan de Déu 1
IP2IPO INNOVATIONS LIMITED 1
Anilur Pharma, S.L. 1
Letowa Inc. 1
University of California 1
DIRECTEDMETAL 3D SL. 1
Tekscend Photomask Corp. 1
Murata 1
Animal Microbiome Analytics, Inc. (D/B/A Animalbiome) 1
Vulcan Bio Corporation 1
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca 1
ADICET THERAPEUTICS, INC. 1
Nokia Solutions and Networks Oy 1

Top Art Units

Art UnitApps
17377
16746
16294
16283
16533
26463
17453
16823
26432
17232

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19537121 N-PHENYL-3-(2,5-DIOXOPYRROLIDIN-1-YL)PROPANAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS DUX4 INHIBITORS FOR THE TREATMENT OF E.G. NEUROMUSCULAR DISORDERS Altay Therapeutics, Inc. CORNET, JEAN P 1628 §102§103§112 Final Rejection — Pending Feb 11, 2026
19531099 FIBER BLEND COMPOSITIONS AND METHODS OF USE THEREOF Animal Microbiome Analytics, Inc. MERRIAM, ANDREW E 1791 §102§103§112 Final Rejection — Pending Feb 05, 2026
19366131 Products and Methods for Therapeutic Administration of Microorganisms to Non-Human Animals Animal Microbiome Analytics, Inc. BOWERS, ERIN M 1653 §103§112 Final Rejection — Pending Oct 22, 2025
19345449 DISPLAY DEVICE Nalux Co., Ltd. CATTANACH, COLIN J 2875 §102§103 Final Rejection — Pending Sep 30, 2025
19288840 CONFIGURED GRANTS FOR SIDELINK POSITIONING Nokia Technologies Oy LAFONTANT, GARY 2646 §102 Final Rejection — AI Ready Aug 01, 2025
19287566 COPING WITH CONSISTENT LISTEN-BEFORE-TALK FAILURE Nokia Technologies Oy HTUN, SAN A 2643 §103 Non-Final OA — AI Ready Jul 31, 2025
19240480 5 WHY SUMMARY FOR PROBLEM ANALYSIS IN OBSERVABILITY SYSTEMS Solarwinds Worldwide, LLC KO, CHAE M 2114 §101§102§103§112 Non-Final OA — Pending Jun 17, 2025
19231752 SECURE PLATFORM AND DATA REPOSITORY FOR FUR OR SKIN COMMODITIES We Plan For S.A. GARG, YOGESH C §101§112Other Non-Final OA — Pending Jun 09, 2025
19222730 STING AGONIST IMMUNOSTIMULATORY ANTIBODY DRUG CONJUGATES Astellas Pharama Inc. CARTER, SANDRA DILLAHUNT 1674 §112 Non-Final OA — Pending May 29, 2025
19219645 ORTHODONTIC DEVICE Orthodontic Research And Development, S.L. MAI, HAO D §102§103 Non-Final OA — Pending May 27, 2025
19194738 CURRENCY MANAGEMENT SYSTEM AND ELECTRONIC SIGNATURE DEVICE Gve Ltd. BUI, TOAN D. §101§103 Non-Final OA — Pending Apr 30, 2025
19122881 LIQUID DELIVERY DEVICE Sumitomo Bakelite Co., Ltd. HERRMANN, JOSEPH S 3746 §103§112 Non-Final OA — Pending Apr 21, 2025
19112742 UNITARY REAR RAIL STRUCTURE FOR A VEHICLE AND METHODS Autotech Engineering S.L. O'NEILL, MATTHEW JAMES 3614 §102§103 Final Rejection 9d overdue Pending Mar 18, 2025
19060416 IMAGING OPTICAL SYSTEM Keiji Ikemori SUMLAR, JOURNEY F DP Non-Final OA — Pending Feb 21, 2025
19014842 PANEL WITH CONNECTOR Varidesk, LLC MAESTRI, PATRICK J §102§103§112 Non-Final OA — Pending Jan 09, 2025
19013591 LITHIUM-STUFFED GARNET ELECTROLYTES WITH A REDUCED SURFACE DEFECT DENSITY AND METHODS OF MAKING AND USING THE SAME Quantumscape Battery, Inc. MURATA, AUSTIN 1712 §103 Final Rejection 29d Pending Jan 08, 2025
19010569 METHOD OF MACHINING MOLD FOR MICROLENS ARRAY Nalux Co., Ltd. RAMOS, NICOLE N §112 Non-Final OA — Pending Jan 06, 2025
18985088 Apparatus Utilizing Smart Fabrics for Providing Protection of the Head and Brain from Injury in Six Degrees of Freedom Scarfe Technologies, Inc. NUNNERY, GRADY ALEXANDER 3732 §101§103§112 Non-Final OA 46d overdue Pending Dec 18, 2024
18875529 BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY Nikang Therapeutics, Inc. SHTERENGARTS, SAMANTHA L 1629 §112 Non-Final OA — Pending Dec 16, 2024
18871132 METHODS AND SYSTEMS FOR THREE-DIMENSIONAL PRINTING Prellis Biologics, Inc. AHMED ALI, MOHAMED K 1743 §103 Non-Final OA — Pending Dec 02, 2024
18870879 FIBRE FOR FABRIC AND FABRIC Gale Pacific Limited TAVARES-CROCKETT, ULA CORINNA §102§103 Non-Final OA — Pending Dec 02, 2024
18868902 AXIAL INTERNAL COMBUSTION ENGINE Innengine, S.L. KIM, JAMES JAY 3747 §102§103§112 Non-Final OA — Pending Nov 25, 2024
18944944 PRESS FIT CONDULET DEVICES, ASSEMBLIES SYSTEMS AND METHODS FOR ELECTRICAL RACEWAY FABRICATION Eaton Intelligent Power Limited MCALLISTER, MICHAEL F §101§102§103 Non-Final OA — Pending Nov 12, 2024
18940077 THIN FILM TYPE FILTER FOR ATTENUATING LIGHT AND METHOD OF PRODUCING THE SAME Nalux Co., Ltd. AHVAZI, BIJAN §103§112 Non-Final OA — Pending Nov 07, 2024
18862043 CERAMIC MATRIX COMPOSITE AND METHOD FOR PRODUCING THE SAME Tosoh Corporation SCHLEIS, DANIEL J 1784 §102 Non-Final OA — Pending Oct 31, 2024
18861569 EMULSION BLEND FOR COATING CARBONATES Specialty Minerals (Michigan) Inc. HUANG, CHENG YUAN §103§112 Non-Final OA — Pending Oct 29, 2024
18859321 SEALING APPARATUS AND METHOD Automated Industrial Robotics Wakefield Limited SELLS, JAMES D 1745 §103 Non-Final OA — Pending Oct 23, 2024
18923249 OXYGEN GENERATING FACE MASKS Dermoq, Inc. LEE, SIN J 1615 §102§103DP Non-Final OA — Pending Oct 22, 2024
18915097 PRODUCTION OF ISOPRENOIDS Amyris, Inc. RAGHU, GANAPATHIRAM DP Non-Final OA — Pending Oct 14, 2024
18855291 METHOD FOR STYRENE MONOMER PRODUCTION Repsol, S.A VASISTH, VISHAL V §103 Non-Final OA — Pending Oct 08, 2024
18906619 OLEFINS AND METHODS FOR MAKING THE SAME Amyris, Inc. ROBINSON, RENEE E §102§103 Non-Final OA — Pending Oct 04, 2024
18904545 OPTICAL SYSTEM PROVIDED WITH ATTENUATING AREA AND METHOD OF PRODUCING THE SAME Nalux Co., Ltd. WONG, TINA MEI SENG §103§112 Non-Final OA — Pending Oct 02, 2024
18898082 MYST Inhibitors Isosterix, Inc. HASTINGS, ALISON AZAR §102§112DP Non-Final OA — Pending Sep 26, 2024
18896091 COMMUNICATING WEIGHT SENSOR UNITS AND TECHNIQUES FOR USING SAME Inventor-E Limited SADATE-MOUALEU, MIREILLE SANDRA §103§112 Non-Final OA — Pending Sep 25, 2024
18882295 INTERACTIVE VIRTUAL OBJECT PLACEMENT WITH CONSISTENT PHYSICAL REALISM Rembrand, Inc. WU, MING HAN 2618 §103 Non-Final OA 6d Pending Sep 11, 2024
18843455 IMAGING DEVICE AND IMAGING METHOD Nikon Corporation SCHNASE, PAUL DANIEL 2877 §102§103§112 Non-Final OA 62d Pending Sep 03, 2024
18821962 DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO Engene, Inc. BURKHART, MICHAEL D §101DP Non-Final OA — Pending Aug 30, 2024
18811626 IMAGE FORMING SYSTEM AND STORAGE MEDIUM Konica Minolta, Inc. DO, ANDREW V 2852 §102§103 Final Rejection 29d Pending Aug 21, 2024
18795968 METAL FOIL FOR SPRING MEMBER, SPRING MEMBER FOR ELECTRONIC DEVICE, PRODUCTION METHOD FOR METAL FOIL FOR SPRING MEMBER, AND PRODUCTION METHOD FOR SPRING MEMBER FOR ELECTRONIC DEVICE Toppan Holdings Inc. SCHWARTZ, CHRISTOPHER P §112DP Non-Final OA — Pending Aug 06, 2024
18835996 CALENDERED CATHODE COMPOSITIONS AND METHODS OF MAKING THEREOF Quantumscape Battery, Inc. HILTON, ALBERT MICHAEL 1723 §103 Non-Final OA — Pending Aug 05, 2024
18776978 RAPID CERAMIC PROCESSING TECHNIQUES AND EQUIPMENT Quantumscape Battery, Inc. WILSON, GREGORY A 3762 §102§112 Non-Final OA — Pending Jul 18, 2024
18776025 COMPOSITIONS AND METHODS FOR WOUND TREATMENT Eluciderm Inc. BERRIOS, JENNIFER A 1613 §112 Non-Final OA — Pending Jul 17, 2024
18728655 METHOD AND APPARATUS FOR SPLITTING DOWNLINK DATA IN A DUAL/MULTI CONNECTIVITY SYSTEM Nokia Solutions and Networks Oy DONABED, NINOS 2444 §101 Final Rejection 111d overdue AI Ready Jul 12, 2024
18767515 PROCESS FOR PRODUCTION OF HYDRAULIC-CARBONATING BINDER SYSTEMS THROUGH MECHANOCHEMICAL ACTIVATION OF MINERALS Carbonbuilt, Inc. GREEN, ANTHONY J DP Non-Final OA — Pending Jul 09, 2024
18727674 DEVICE AND METHOD FOR REGULATING RELEASE OF ADENOSINE IN ORGANISM, AND USE Wenzhou Adopharm Technology Co., Ltd. WILSON, KAYLEE R §101§102§103§112 Non-Final OA — Pending Jul 09, 2024
18727536 PULP FOR GLASS INTERLEAVING PAPER, GLASS INTERLEAVING PAPER, AND PRODUCTION METHOD THEREFOR Oji Holdings Corporation VERA, ELISA H 1748 §103 Final Rejection 46d overdue Pending Jul 09, 2024
18727041 PHASE SHIFT MASK AND METHOD FOR MANUFACTURING PHASE SHIFT MASK Tekscend Photomask Corp. FRASER, STEWART A §103Other Non-Final OA — Pending Jul 05, 2024
18758003 MECHANISM FOR CELL ACTIVATION Nokia Technologies Oy HOANG, THAI D §102§112 Non-Final OA — Pending Jun 28, 2024
18723184 SUPPRESSION OF NON-SPECIFIC SIGNALS BY EXONUCLEASES IN FISH EXPERIMENT California Institute Of Technology WOOLWINE, SAMUEL C §102§103§112 Non-Final OA — Pending Jun 21, 2024
18740388 FORCE-LIMITING ACCESS SYSTEM AND METHOD OF USE Calyxo, Inc. ZAMORY, JUSTIN L §103 Non-Final OA — Pending Jun 11, 2024
18710244 MACHINE-LEARNING AGENT PARAMETER INITIALIZATION IN WIRELESS COMMUNICATION NETWORK Nokia Solutions and Networks Oy SEN, ANINDITA 2478 §103 Non-Final OA — Pending May 15, 2024
18650555 MULTI-PURPOSE JEWELRY WITH VARIABLE APPEARANCE Love Random Life MORGAN, EMILY M 3677 §103§112 Non-Final OA 15d Pending Apr 30, 2024
18704362 CONTROLLING ACCESS FOR DEVICES WITH DIFFERENT CAPABILITIES Nokia Technologies Oy NGUYEN, CHUONG M 2411 §102§103§112Other Non-Final OA — Pending Apr 24, 2024
18703169 CATHOLYTES FOR A SOLID-STATE BATTERY Quantumscape Battery, Inc. LUSTGRAAF, BENJAMIN T §103§112 Non-Final OA — Pending Apr 19, 2024
18638420 ANTI-BCMA ANTIBODIES AND TREATMENT METHODS Sutro Biopharma, Inc. KAUFMAN, CLAIRE M 1674 §112 Non-Final OA 15d Pending Apr 17, 2024
18701343 WIRELESS POSITIONING Nokia Technologies Oy KAMARA, MOHAMED A 2412 §103 Final Rejection — Pending Apr 15, 2024
18700682 HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS FOR THE TREATMENT OF BLADDER CANCER Nikang Therapeutics, Inc. CHENG, KAREN 1623 §103DP Non-Final OA — Pending Apr 11, 2024
18699709 EARPHONE AND BIOMETRIC INFORMATION MEASUREMENT DEVICE VIE, INC. BLAISE, BRADFORD CHRISTOPHER 3794 §103 Final Rejection — Pending Apr 09, 2024
18699011 METHODS AND COMPOSITIONS FOR REDUCING SMOKE TAINT IN FERMENTED BEVERAGES Berkeley Fermentation Science Inc. CHEONG, CHEOM-GIL 1793 §112 Non-Final OA — Pending Apr 05, 2024
18622758 METHOD AND APPARATUS TO RETRIEVE OBSCURED FORM INFORMATION Konica Minolta Business Solutions U.S.A., Inc. ESQUINO, CALEB LOGAN 2677 §103 Final Rejection 30d Pending Mar 29, 2024
18696707 ENABLING DISTRIBUTED NON-ACCESS STRATUM TERMINATIONS Nokia Technologies Oy CHAU, PETER P 2476 §103§112 Final Rejection — Pending Mar 28, 2024
18605432 METHODS AND USES OF BORON COMPOUNDS IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIUM INFECTIONS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SAME Micurx Pharmeceuticals, Inc. GAUGER, PAUL RANDALL 1629 DP Non-Final OA — Pending Mar 14, 2024
18605444 PRODRUGS OF BORON COMPOUNDS AND THEIR USE IN TREATING BACTERIAL INFECTIONS Shanghai Micurx Pharmaceuticals Co., Ltd. GAUGER, PAUL RANDALL 1629 DP Non-Final OA — Pending Mar 14, 2024
18691159 METHOD FOR CARTILAGE REGENERATION AND REGROWTH FOLLOWING INJURY Eluciderm Inc. SONG, JIANFENG 1613 §103DP Final Rejection — Pending Mar 12, 2024
18690169 PEPTIDE T14 FOR BRAAK STAGING Neuro-Bio Ltd. CHERNYSHEV, OLGA N §101§112 Non-Final OA — Pending Mar 07, 2024
18596252 SECURITY RISK LEVEL ASSESSMENT OF ASSETS AND SOFTWARE COMPONENTS Solarwinds Worldwide, LLC TRAN, NAM T 2455 §103 Final Rejection 9d Pending Mar 05, 2024
18689001 DEVICES, METHODS AND COMPUTER READABLE MEDIA FOR MULTIPLEXING NACK-ONLY HARQ FEEDBACK Nokia Technologies Oy SOHRAB, MALICK ARIF 2414 §103§112 Non-Final OA — AI Ready Mar 04, 2024
18593737 IMAGE FORMING SYSTEM AND METHOD OF CONTROLLING IMAGE FORMING SYSTEM Konica Minolta, Inc. PACHOL, NICHOLAS C 2699 DP Final Rejection — Pending Mar 01, 2024
18686755 MICROFLUIDIC-BASED FIBER FORMATION METHODS AND SYSTEMS Aspect Biosystems Ltd. SWANSON, ANDREW L 1745 §103§112 Non-Final OA — Pending Feb 26, 2024
18685754 MULTI-ZONE FUEL ELEMENT Lightbridge Corporation COOPERRIDER, KELLY MARIE 3646 §102§103§112 Non-Final OA — Pending Feb 22, 2024
18439596 POLYCARBONATE DIOL, URETHANE RESIN, AND COATING AGENT Tosoh Corporation LEONARD, MICHAEL L §102§103 Non-Final OA — Pending Feb 12, 2024
18682879 SMALL MOLECULE UREA DERIVATIVES AS STING ANTAGONISTS Curadev Pharma Pvt. Ltd. ROMERO, KRISTEN WANG 1624 §102§103§112 Non-Final OA — Pending Feb 09, 2024
18294962 EARLY MEASUREMENT REPORTING DURING SMALL DATA TRANSMISSION Nokia Technologies Oy RIVAS, RAUL 2471 §103 Non-Final OA — Pending Feb 02, 2024
18293122 METHODS FOR SYNTHESIS OF RACEMIC, SCALEMIC, AND CHIRAL ALPHA-TOCOTRIENOL QUINONE Ptc Therapeutics, Inc. MOORE, SUSANNA 1624 §102§103§112 Final Rejection — Pending Jan 29, 2024
18291124 STAR-SHAPED PASP-OLIGOAMINE DERIVATIVES Polypeptide Therapeutic Solutions, S.L. KARST, DAVID THOMAS §112 Non-Final OA — Pending Jan 22, 2024
18580926 COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL DISEASES Shanghai Micurx Pharmaceuticals Co., Ltd. JAUHARI, SACHI §103§112Other Non-Final OA — Pending Jan 19, 2024
18580921 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL CANCERS Shanghai Micurx Pharmaceutical Co., Ltd. COFFA, SERGIO §112 Non-Final OA — Pending Jan 19, 2024
18416256 PAGING WITH CELL DISCONTINUOUS TRANSMISSION Nokia Technologies Oy GHULAMALI, QUTBUDDIN 2632 §112 Non-Final OA — Pending Jan 18, 2024
18397190 METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES BIOGEN MA INC. VU, JAKE MINH §112Other Non-Final OA — Pending Dec 27, 2023
18568815 CATECHOLAMINE-BASED MEMBRANE, PROCESS FOR ITS PREPARATION AND USES THEREOF CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS AZPURU, CARLOS A 1617 §103 Non-Final OA — Pending Dec 09, 2023
18567199 UPLINK TRANSMIT POWER CONTROL Nokia Solutions and Networks Oy HUANG, WEIBIN 2471 §103 Non-Final OA — Pending Dec 05, 2023
18563676 LINKED AMPLIFICATION TETHERED WITH EXPONENTIAL RADIANCE California Institute Of Technology SALMON, KATHERINE D 1682 §103 Final Rejection — Pending Nov 22, 2023
18562642 PHYSICAL DOWNLINK CONTROL CHANNEL CONFIGURATION Nokia Technologies Oy CHRISS, ANDREW W 2472 §103 Non-Final OA — Pending Nov 20, 2023
18560836 METHODS AND COMPOSITIONS FOR GAMMA-DECALACTONE BIOSYNTHESIS IN FERMENTED BEVERAGES Berkeley Fermentation Science Inc. MISHRA, DEEPA 1657 §102§103§112 Non-Final OA — Pending Nov 14, 2023
18289513 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE Nurix Therapeutics, Inc. HUI, SAN MING R 1627 DP Non-Final OA — Pending Nov 03, 2023
18558005 TRANSMISSION FOR TIME SYNCHRONIZATION Nokia Technologies Oy NGUYEN, CHUONG M 2411 §103 Final Rejection 35d overdue AI Ready Oct 30, 2023
18495873 ELECTROLYTE SEPARATORS INCLUDING LITHIUM BOROHYDRIDE AND COMPOSITE ELECTROLYTE SEPARATORS OF LITHIUM-STUFFED GARNET AND LITHIUM BOROHYDRIDE Quantumscape Battery, Inc. MCCONNELL, WYATT P 1727 §101DP Non-Final OA — Pending Oct 27, 2023
18286721 COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME BIOGEN MA INC. AEDER, SEAN E 1642 §102§103§112 Non-Final OA — Pending Oct 12, 2023
18373229 TOOL GUIDING DEVICE FOR KIDNEY STONE TREATMENT APPARATUS Calyxo, Inc. CHRISTIANSON, SKYLAR LINDSEY 3792 §102§103DP Non-Final OA — Pending Sep 26, 2023
18372927 COATING MATERIAL COMPOSITION, KIT, COATING FILM, AND COATING FILM FORMING METHOD Tosoh Corporation SERGENT, RABON A 1765 §103 Final Rejection — Pending Sep 26, 2023
18281542 PHASE SHIFT MASK BLANK, PHASE SHIFT MASK, AND METHOD FOR MANUFACTURING PHASE SHIFT MASK Tekscend Photomask Corp. CHACKO DAVIS, DABORAH 1737 §102 Final Rejection — Pending Sep 11, 2023
18244144 OPTICAL FILM, DISPLAY MEMBER AND DISPLAY DEVICE USING THE SAME Toppan Tomoegawa Optical Films Co., Ltd. VU, PHU 2871 §103 Final Rejection — Pending Sep 08, 2023
18280939 POLARIZER PROTECTIVE FILM Osaka Gas Chemicals Co., Ltd. STRAH, ELI D 1782 §103§112 Non-Final OA — Pending Sep 07, 2023
18462129 CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS Innovo Therapeutics, Inc. WILSON, JERICA KATLYNN 1621 §112 Non-Final OA — Pending Sep 06, 2023
18547085 FUSION PROTEINS COMPRISING TWO RING DOMAINS UNITED KINGDOM RESEARCH AND INNOVATION KIEFER, DALTON EDWARD 1652 §102§112DP Non-Final OA — Pending Aug 18, 2023
18277944 COMBINATION GENE THERAPY FOR TREATMENT OF METASTATIC CANCER Engene, Inc. POLIAKOVA-GEORGAN, EKATERINA 1637 §102§103DP Non-Final OA — Pending Aug 18, 2023
18449374 ACCESS MANAGEMENT FOR REDUCED CAPABILITY DEVICES Nokia Technologies Oy HAMPTON, TARELL A 2476 §103§112 Final Rejection — Pending Aug 14, 2023
18277053 REFLECTIVE PHOTOMASK BLANK AND REFLECTIVE PHOTOMASK Tekscend Photomask Corp. FRASER, STEWART A 1724 §103 Final Rejection — Pending Aug 11, 2023
18276541 A NETWORK REPEATER Nokia Solutions and Networks Oy WELTE, BENJAMIN PETER 2477 §103 Final Rejection 9d overdue AI Ready Aug 09, 2023
18275797 MICRO RNA LIVER CANCER MARKERS AND USES THEREOF The Cleveland Clinic Foundation YU, TIAN NMN 1681 §101§103 Non-Final OA — Pending Aug 03, 2023
18357956 ANTI-CD74 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI CD74 ANTIBODY CONJUGATES AND METHODS OF USING ANTI-CD74 ANTIBODY CONJUGATES Sutro Biopharma, Inc. HOWARD, ZACHARY C 1674 §112Other Non-Final OA — Pending Jul 24, 2023
18273863 ELECTROLYTE ADDITIVES FOR ZINC BATTERIES Octet Scientific, Inc. SLIFKA, SARAH A 1724 §102§103 Non-Final OA — Pending Jul 24, 2023
18302603 BIOMARKERS FOR CBL, AND COMPOSITIONS AND METHODS FOR THEIR USE Nurix Therapeutics, Inc. GIERE, REBECCA M 1677 §101§112 Non-Final OA — Pending Jul 24, 2023
18273261 ACYL ACTIVATING ENZYMES FOR PREPARATION OF CANNABINOIDS BAYMEDICA, INC. SAIDHA, TEKCHAND 1652 §102§112 Non-Final OA 1d overdue Pending Jul 19, 2023
18222413 ENHANCED POLYPHASE DIGITAL PRE-DISTORTION STRUCTURE WITH LOW COMPLEXITY IN RADIO TRANSMITTER Nokia Solutions and Networks Oy TRAN, PABLO N 2643 §112 Non-Final OA — Pending Jul 14, 2023
18271032 REFLECTIVE PHOTOMASK BLANK AND REFLECTIVE PHOTOMASK Tekscend Photomask Corp. CHACKO DAVIS, DABORAH 1737 §102 Final Rejection — Pending Jul 05, 2023
18215093 BETA-GLUCURONIDE LINKER-PAYLOADS, PROTEIN CONJUGATES THEREOF, AND METHODS THEREOF Sutro Biopharma, Inc. GALSTER, SAMUEL LEONARD 1693 §103DP Non-Final OA — Pending Jun 27, 2023
18339707 METAL NEGATIVE ELECTRODE ULTRASONIC CHARGING Quantumscape Battery, Inc. PACHECO, ALEXIS BOATENG 2859 §103 Final Rejection 46d Pending Jun 22, 2023
18256522 ENABLING DYNAMIC SWITCHING BETWEEN MULTIPLE TRANSMISSION RECEPTION POINTS AND SINGLE TRANSMISSION RECEPTION POINTS PHYSICAL UPLINK CONTROL CHANNEL SCHEMES Nokia Technologies Oy LINDENBAUM, ALAN LOUIS 2413 §103 Non-Final OA — Pending Jun 08, 2023
18321867 CHANNEL ASSESSMENT DETERMINATION IN TELECOMMUNICATION SYSTEMS Nokia Technologies Oy SCIACCA, SCOTT M 2478 §103 Non-Final OA 19d AI Ready May 23, 2023
18200527 FABRIC BIOME BIOPLASTICS LIMITED GILLETT, JENNIFER ANN 1789 §103 Non-Final OA 12d Pending May 22, 2023
18253197 HEAVY CHAIN ANTIBODIES BINDING TO FOLATE RECEPTOR ALPHA Teneoseven, Inc. MERTZ, PREMA MARIA 1674 §112 Non-Final OA — Pending May 16, 2023
18036620 BIPHASIC SUBCUTANEOUS DOSING REGIMENS FOR ANTI-VLA-4 ANTIBODIES BIOGEN MA INC. MIDDLETON, DANAYA L 1674 §102§103§112DP Final Rejection 79d overdue Pending May 11, 2023
18036472 GENETICALLY ENGINEERED YEAST CELLS AND METHODS OF USE THEREOF Berkeley Fermentation Science Inc. POPA, ILEANA 1633 §103 Final Rejection 69d Pending May 11, 2023
18140572 LAMINATING APPARATUS, IMAGE FORMING SYSTEM, STORAGE MEDIUM, AND CONTROL DEVICE Konica Minolta, Inc. CAILLOUET, CHRISTOPHER C 1745 §103 Final Rejection 30d overdue Pending Apr 27, 2023
18033187 COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS Inmed Pharmaceuticals Inc. MOU, LIYUAN 1628 §102§103§112 Final Rejection 45d overdue Pending Apr 21, 2023
18031321 REFLECTIVE MASK AND METHOD FOR PRODUCING REFLECTIVE MASK Tekscend Photomask Corp. EOFF, ANCA 1737 §102§112 Non-Final OA — Pending Apr 11, 2023
18030875 NLRP3 ACTIVATORS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES OR CANCER BY ACTIVATING NLRP3 INFLAMMASOME Albert-Ludwigs-Universität Freiburg TOWNSLEY, SARA ELIZABETH 1629 §102§112 Non-Final OA — Pending Apr 07, 2023
18028515 PEPTIDIC CONJUGATES OF SN38 USEFUL IN THE TREATMENT OF CANCER Hospital Sant Joan De Deu DABKOWSKI, ERINNE R 1654 §112DP Non-Final OA — Pending Mar 24, 2023
18028498 ZIP12 ANTIBODY Ip2Ipo Innovations Limited LI, RUIXIANG 1674 §112 Non-Final OA — Pending Mar 24, 2023
18028159 REFLECTIVE PHOTOMASK BLANK AND REFLECTIVE PHOTOMASK Tekscend Photomask Corp. ANGEBRANNDT, MARTIN J 1737 §103 Final Rejection 48d Pending Mar 23, 2023
18027821 METHOD OF APPLYING FORCE TO ORGANISM AND DEVICE FOR APPLYING FORCE TO ORGANISM Nikon Corporation MARTIN, PAUL C 1653 §102§112 Final Rejection — Pending Mar 22, 2023
18027825 OPERATION METHOD AND OPERATION DEVICE FOR LIVING BODY Nikon Corporation BOWERS, NATHAN ANDREW 1799 §102§103§112Other Final Rejection 77d overdue Pending Mar 22, 2023
18027816 METHOD OF MANIPULATING ORGANISM AND DEVICE FOR MANIPULATING ORGANISM Nikon Corporation BERKE-SCHLESSEL, DAVID W 1796 §102§103DP Non-Final OA — Pending Mar 22, 2023
18025296 BEAM FAILURE REPORTING Nokia Technologies Oy DOUGLAS, MICHELE CAMILLE 2646 — Final Rejection 40d AI Ready Mar 08, 2023
18044200 CATHODE COATING Quantumscape Battery, Inc. CARVALHO JR., ARMINDO 1729 §103 Final Rejection — Pending Mar 06, 2023
18043899 C-PHYCOCYANIN FOR USE IN THE TREATMENT AND/OR PREVENTION OF PERIPHERAL NEUROPATHY Anilur Pharma, S.L. BASQUILL, SEAN M 1614 §103 Final Rejection 217d overdue Pending Mar 02, 2023
18113705 COMMUNICATING WEIGHT SENSOR UNITS, ASSET TAGS AND DISPENSING UNITS AND ENCLOSURES, AND TECHNIQUES FOR USING SAME Inventor-E Limited HULS, NATALIE F 2855 §103 Final Rejection 46d Pending Feb 24, 2023
18157700 ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES Octet Scientific, Inc. HARRIS, MARY GRACE 1729 §102§103 Non-Final OA 19d Pending Jan 20, 2023
18012916 NOVEL METHOD OF MEASURING ENZYME ACTIVITY Cj Cheiljedang Corporation EIX, EMILY FAY 1653 §102 Non-Final OA — Pending Dec 24, 2022
18086538 CATALYST FOR FUEL CELLS, ELECTRODE CATALYST LAYER, MEMBRANE ELECTRODE JOINED BODY, SOLID POLYMER TYPE FUEL CELL, METHOD FOR PRODUCING TITANIUM OXIDE FOR CATALYST CARRIERS, AND METHOD FOR PRODUCING CATALYST FOR FUEL CELLS Toppan Inc. CONLEY, OI K 1752 §102§103§112 Non-Final OA — Pending Dec 21, 2022
18074369 METHOD OF MAPPING SPATIAL DISTRIBUTIONS OF CELLULAR COMPONENTS California Institute Of Technology LU, FRANK WEI MIN 1683 §103§112Other Final Rejection 43d overdue Pending Dec 02, 2022
18072817 EQUIPMENT BAG ATTACHMENT MECHANISM Letowa Inc. DO, ROWLAND 3677 §102§103 Final Rejection 71d Pending Dec 01, 2022
17990661 MITIGATION OF EPILEPTIC SEIZURES BY COMBINATION THERAPY USING BENZODIAZEPINES AND NEUROSTEROIDS The Regents of the University of California HOWELL, THEODORE R 1628 §112Other Final Rejection — Pending Nov 19, 2022
17977954 LASER DEVICES AND METHODS FOR LASER METAL DEPOSITION Directedmetal 3D Sl. LEE JR, WOODY A 3761 §112 Final Rejection — Pending Oct 31, 2022
17920386 REFLECTIVE PHOTOMASK BLANK AND REFLECTIVE PHOTOMASK Tekscend Photomask Corp. VINEIS, FRANK J 1737 §103Other Non-Final OA — Pending Oct 20, 2022
17958232 METHOD AND APPARATUS FOR TEXT RESTORATION IN CHARACTER RECOGNITION Konica Minolta Business Solutions U.S.A., Inc. MORSE, GREGORY ALLAN 2663 §112 Non-Final OA — Pending Sep 30, 2022
17957238 ASSIGN MANAGEMENT RELATED ENTITIES TO GEOGRAPHICAL AREAS Nokia Technologies Oy KIDANE, MEHERET WOLDEGEBREAL 2464 §103 Final Rejection — AI Ready Sep 30, 2022
17909730 CYCLIC PEPTIDES FROM THE C-TERMINUS OF ACETYLCHOLINESTERASE FOR TREATMENT OF SKIN DISORDERS AND FOR COSMETICAL USE Neuro-Bio Ltd. HELLMAN, KRISTINA M 1654 §103§112Other Non-Final OA 19d Pending Sep 06, 2022
17886039 ELECTRONIC COMPONENT WITH MOULDED PACKAGE Murata Manufacturing Co., Ltd. HIBBERT, DANIEL JOHNATHAN 2899 §103§112 Final Rejection 9d overdue Pending Aug 11, 2022
17798552 SMALL MOLECULE STING ANTAGONISTS Curadev Pharma Pvt. Ltd. KENYON, JOHN S 1625 §102§112 Non-Final OA — Pending Aug 09, 2022
17796565 VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME Cj Cheiljedang Corporation MORGAN, BAILEY MICHELLE 1645 §102 Non-Final OA — Pending Jul 29, 2022
17782163 SYSTEM AND METHODS FOR MANIPULATION OF THE ORAL MICROBIOME IN MAMMALS Animal Microbiome Analytics, Inc. (D/B/A Animalbiome) HINES, JANA A 1645 §103§112 Non-Final OA — Pending Jun 02, 2022
17778402 REFLECTIVE PHOTOMASK BLANK AND REFLECTIVE PHOTOMASK Tekscend Photomask Corp. VINEIS, FRANK J 1737 §103DP Non-Final OA — Pending May 19, 2022
17775265 BIFUNCTIONAL COMPOUNDS FOR GRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY Nurix Therapeutics, Inc. HEITMEIER, KENDALL NICOLE 1621 §103§112 Non-Final OA 39d Pending May 06, 2022
17772340 REFLECTIVE MASK AND PRODUCTION METHOD FOR REFLECTIVE MASK Tekscend Photomask Corp. COSGROVE, JAYSON D 1737 §103 Final Rejection 5d Pending Apr 27, 2022
17727395 ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE Sutro Biopharma, Inc. HUYNH, PHUONG N 1641 §112Other Final Rejection 2d overdue Pending Apr 22, 2022
17703162 THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES Prellis Biologics, Inc. WOLLSCHLAGER, JEFFREY MICHAEL 1742 §103 Non-Final OA — Pending Mar 24, 2022
17763156 TARGETED AUTOPHAGY CONJUGATES AND METHODS Vulcan Bio Corporation BURKETT, DANIEL JOHN 1626 §112 Final Rejection — Pending Mar 23, 2022
17618837 SYNTHROCYTE: ERYTHROCYTE-MIMICKING REAGENT AND FAST METHODS FOR PATHOGEN CHARACTERIZATION AND SEROLOGY TESTING Fundació Hospital Universitari Vall D'Hebron - Institut De Recerca IVICH, FERNANDO NMN 1678 §112 Non-Final OA — Pending Dec 13, 2021
17606003 COMPOSITIONS AND METHODS FOR USE OF CANNABINOIDS FOR NEUROPROTECTION Inmed Pharmaceuticals Inc. REILLY, SOPHIA JANE 1627 §101§102§103§112Other Non-Final OA — Pending Oct 22, 2021
17489723 DEVICES AND METHODS FOR MINIMALLY INVASIVE KIDNEY STONE REMOVAL BY COMBINED ASPIRATION AND IRRIGATION Calyxo, Inc. MCGINNITY, JAMES RYAN 3771 §103 Non-Final OA — Pending Sep 29, 2021
17438921 REVERSIBLE COATING OF CHITOSAN-NUCLEIC ACID NANOPARTICLES AND METHODS OF THEIR USE Engene, Inc. ROGERS, JAMES WILLIAM 1618 §103§112 Non-Final OA — Pending Sep 13, 2021
17436548 COMPOSITIONS AND METHODS FOR BIOSYNTHESIS OF TERPENOIDS OR CANNABINOIDS IN A HETEROLOGOUS SYSTEM Inmed Pharmaceuticals Inc. REGA, KYLE THOMAS 1636 §103 Final Rejection — Pending Sep 03, 2021
17298903 METHODS FOR SELECTIVE IN VIVO EXPANSION OF GAMMA DELTA T-CELL POPULATIONS AND COMPOSITIONS THEREOF Adicet Therapeutics, Inc. SKELDING, ZACHARY S 1644 §112 Non-Final OA 2d overdue Pending Jun 01, 2021
17281159 METHODS OF MAKING AND USING AN ELECTROCHEMICAL CELL COMPRISING AN INTERLAYER Quantumscape Battery, Inc. SMITH, JEREMIAH R 1723 §103 Non-Final OA 96d overdue Pending Mar 29, 2021
17146917 FLEXIBLE DATA TRANSMISSION METHODS CONSIDERING CONFIGURED GRANT TIMERS Nokia Technologies Oy SEFCHECK, GREGORY B 2477 §103 Final Rejection — Pending Jan 12, 2021
16770889 MULTIPLEX LABELING OF MOLECULES BY SEQUENTIAL HYBRIDIZATION BARCODING WITH RAPID SWITCHING AND REHYBRIDIZATION OF PROBES California Institute Of Technology SISSON, BRADLEY L 1682 §103 Non-Final OA — Pending Jun 08, 2020
16572140 SYSTEM AND METHOD FOR THE PRODUCTION AND TREATMENT OF FUR, SKIN, AND LEATHER COMMODITIES We Plan For S.A. WORRELL, KEVIN 1789 §103 Non-Final OA — Pending Sep 16, 2019
15713597 RECORDING AND MAPPING LINEAGE INFORMATION AND MOLECULAR EVENTS IN INDIVIDUAL CELLS California Institute Of Technology JOHANNSEN, DIANA B 1682 §112 Non-Final OA — Pending Sep 22, 2017
14370123 USER EQUIPMENT CAPABILITIES INDICATION TO ENABLE INTELLIGENT HANDOVER DECISION Nokia Solutions and Networks Oy TACDIRAN, ANDRE GEE 2415 §103 Final Rejection 28d AI Ready Jul 01, 2014
13002615 CONFIGURATION OF A COMMUNICATION DEVICE Nokia Siemens Networks OY SHEDRICK, CHARLES TERRELL 2646 §103 Non-Final OA — Pending Jan 31, 2011

Managing Squire Pb (Sfr Office)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month